| Marek's disease virus: from miasma to model N Osterrieder, JP Kamil, D Schumacher, BK Tischer, S Trapp Nature Reviews Microbiology 4 (4), 283-294, 2006 | 509 | 2006 |
| The value of forests to world food security D Pimentel, M McNair, L Buck, M Pimentel, J Kamil Human ecology 25, 91-120, 1997 | 367 | 1997 |
| The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus LF Lee, P Wu, D Sui, D Ren, J Kamil, HJ Kung, RL Witter Proceedings of the National Academy of Sciences 97 (11), 6091-6096, 2000 | 268 | 2000 |
| Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function AJ Hume, JS Finkel, JP Kamil, DM Coen, MR Culbertson Science 320, 797-9, 2008 | 262 | 2008 |
| Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress S Hamirally, JP Kamil, YM Ndassa-Colday, AJ Lin, WJ Jahng, MC Baek, ... PLoS pathogens 5 (1), e1000275, 2009 | 231 | 2009 |
| Pathogen at the gates: human cytomegalovirus entry and cell tropism CC Nguyen, JP Kamil Viruses 10 (12), 704, 2018 | 179 | 2018 |
| A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis S Trapp, MS Parcells, JP Kamil, D Schumacher, BK Tischer, PM Kumar, ... The Journal of experimental medicine 203 (5), 1307-1317, 2006 | 159 | 2006 |
| Horizontal Transmission of Marek's Disease Virus Requires US2, the UL13 Protein Kinase, and gC KW Jarosinski, NG Margulis, JP Kamil, SJ Spatz, VK Nair, N Osterrieder Journal of virology 81 (19), 10575-10587, 2007 | 156 | 2007 |
| The impact of evolving SARS-CoV-2 mutations and variants on COVID-19 vaccines G McLean, J Kamil, B Lee, P Moore, TF Schulz, A Muik, U Sahin, Ö Türeci, ... MBio 13 (2), e02979-21, 2022 | 148 | 2022 |
| Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants S Ikegame, MNA Siddiquey, CT Hung, G Haas, L Brambilla, KY Oguntuyo, ... Nature communications 12 (1), 4598, 2021 | 136 | 2021 |
| Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677 EB Hodcroft, DB Domman, DJ Snyder, KY Oguntuyo, M Van Diest, ... MedRxiv, 2021 | 130 | 2021 |
| A viral regulator of glycoprotein complexes contributes to human cytomegalovirus cell tropism G Li, CC Nguyen, BJ Ryckman, WJ Britt, JP Kamil Proceedings of the National Academy of Sciences 112 (14), 4471-4476, 2015 | 116 | 2015 |
| Marek's Disease Viral Interleukin-8 Promotes Lymphoma Formation through Targeted Recruitment of B Cells and CD4+ CD25+ T Cells AT Engel, RK Selvaraj, JP Kamil, N Osterrieder, BB Kaufer Journal of virology 86 (16), 8536-8545, 2012 | 109 | 2012 |
| Human cytomegalovirus protein kinase UL97 forms a complex with the tegument phosphoprotein pp65 JP Kamil, DM Coen Journal of virology 81 (19), 10659-10668, 2007 | 107 | 2007 |
| vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus JP Kamil, BK Tischer, S Trapp, VK Nair, N Osterrieder, HJ Kung Journal of virology 79 (11), 6984-6996, 2005 | 94 | 2005 |
| Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells M Sharma, JP Kamil, M Coughlin, NI Reim, DM Coen Journal of virology 88 (1), 249-262, 2014 | 87 | 2014 |
| Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex M Sharma, BJ Bender, JP Kamil, MF Lye, JM Pesola, NI Reim, JM Hogle, ... Journal of virology 89 (1), 523-534, 2015 | 81 | 2015 |
| Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera KY Oguntuyo, CS Stevens, CT Hung, S Ikegame, JA Acklin, SS Kowdle, ... MBio 12 (1), 10.1128/mbio. 02492-20, 2021 | 78 | 2021 |
| Alternative promoters drive human cytomegalovirus reactivation from latency D Collins-McMillen, M Rak, JC Buehler, S Igarashi-Hayes, JP Kamil, ... Proceedings of the National Academy of Sciences 116 (35), 17492-17497, 2019 | 67 | 2019 |
| SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines S Pather, SA Madhi, BJ Cowling, P Moss, JP Kamil, S Ciesek, A Muik, ... Frontiers in immunology 14, 1130539, 2023 | 62 | 2023 |
Christopher Cain NguyenSenior Scientist, Stylus Medicine確認したメール アドレス: stylusmedicine.com
